Progressive White Patches on Hands and Face: Diagnosis and Treatment
Immediate Diagnostic Approach
For progressive white patches on the hands and face, vitiligo is the most likely diagnosis and can be made clinically in primary care when the presentation is classical, though atypical cases require dermatologist evaluation. 1
Key Diagnostic Steps
- Check thyroid function with blood tests given the 34% prevalence of autoimmune thyroid disease in vitiligo patients 1, 2
- Rule out fungal infection (tinea versicolor) which presents differently with fine scale and KOH positivity, requiring only 2 weeks of topical ketoconazole 2% cream once daily 3
- Assess disease activity by determining if new lesions have appeared or existing patches have extended in the past 12 months 1, 4
First-Line Treatment Algorithm
For Recent-Onset, Localized Vitiligo
Start with potent or very potent topical corticosteroids (clobetasol propionate 0.05% or betamethasone valerate 0.1%) applied twice daily for a maximum trial of 2 months. 1, 2
- This achieves 15-25% repigmentation in approximately 43% of patients 2
- Critical caveat: Skin atrophy is a common side effect, so limit duration strictly to 2 months 1
Alternative First-Line Option
Topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) should be considered as alternatives to topical steroids, particularly for facial involvement, due to their superior short-term safety profile. 1, 2
- These provide comparable efficacy without the atrophy risk of potent steroids 2
- Can be used for longer durations than corticosteroids 1
Second-Line Treatment for Inadequate Response
For Widespread Disease or Significant Quality of Life Impact
Narrowband UVB phototherapy (311 nm) should be used in preference to oral PUVA for patients who cannot be adequately managed with topical treatments. 1
- Reserve this for darker skin types where repigmentation will be more visible 1
- Monitor with serial photographs every 2-3 months 1, 2
- Maximum of 200 treatments for skin types I-III due to long-term skin cancer risk 2
- Do not use in patients with pale white skin (types I-II) where vitiligo may cause minimal cosmetic concern 1
Surgical Options for Stable Disease
Surgical treatments are reserved exclusively for cosmetically sensitive sites (face and hands) where there have been no new lesions, no Koebner phenomenon, and no extension for at least 12 months. 1, 4
- Split-skin grafting provides better cosmetic and repigmentation results than minigraft procedures 1
- Minigraft is not recommended due to high incidence of side effects and poor cosmetic results 1
Depigmentation for Extensive Disease
For adults with more than 50% body surface area involvement or extensive depigmentation on face and hands who cannot or choose not to pursue repigmentation, monobenzone (monobenzyl ether of hydroquinone) should be considered. 1, 5
- Patients must fully accept the permanent, irreversible nature of complete depigmentation and permanently losing the ability to tan 5
- Onset of depigmentation occurs within 4-12 months of consistent application 5
- Approximately 36% experience repigmentation recurrence requiring retreatment 5
What NOT to Do
Oral dexamethasone cannot be recommended for arresting vitiligo progression due to unacceptable risk of side effects. 1, 2
Conservative Management Option
For adults with pale skin types I-II, it is appropriate to consider no active treatment other than camouflage cosmetics and sunscreens after discussion with the patient. 1
- Cosmetic camouflage can improve quality of life (DLQI improvement from 7.3 to 5.9) 1
- Vitiligo causes minimal cosmetic concern in very pale individuals 1